Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Aptamer Group's Enterprise Value is £3.04 Mil.
Aptamer Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was £-7.12 Mil. Therefore, Aptamer Group's EV-to-EBIT ratio for today is -0.43.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Aptamer Group's Enterprise Value is £3.04 Mil.
Aptamer Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was £-3.95 Mil. Therefore, Aptamer Group's EV-to-EBITDA ratio for today is -0.77.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Aptamer Group's Enterprise Value is £3.04 Mil.
Aptamer Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was £1.04 Mil. Therefore, Aptamer Group's EV-to-Revenue ratio for today is 2.94.
Aptamer Group Enterprise Value Historical Data
The historical data trend for Aptamer Group's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Aptamer Group's Enterprise Value
For the Biotechnology subindustry, Aptamer Group's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aptamer Group's Enterprise Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Aptamer Group's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Aptamer Group's Enterprise Value falls into.
Aptamer Group Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Aptamer Group's Enterprise Value for the fiscal year that ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aptamer Group (LSE:APTA) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Aptamer Group's current Enterprise Value is £3.04 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Aptamer Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was £-7.12 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Aptamer Group's current Enterprise Value is £3.04 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Aptamer Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was £-3.95 Mil.
Aptamer Group's current Enterprise Value is £3.04 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Aptamer Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was £1.04 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aptamer Group Enterprise Value Related Terms
Thank you for viewing the detailed overview of Aptamer Group's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses: Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:APTA has been successfully added to your